{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:45:54Z","timestamp":1782776754478,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":172,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007089","name":"Yancheng Teachers University","doi-asserted-by":"publisher","award":["20KJB310026"],"award-info":[{"award-number":["20KJB310026"]}],"id":[{"id":"10.13039\/501100007089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Pharmacology and Drug Discovery"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.crphar.2023.100159","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T20:05:09Z","timestamp":1687464309000},"page":"100159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Fucoidan alleviates the hepatorenal syndrome through inhibition organic solute transporter \u03b1\/\u03b2 to reduce bile acids reabsorption"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3973-5875","authenticated-orcid":false,"given":"Xiaojuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.crphar.2023.100159_bib1","doi-asserted-by":"crossref","first-page":"12579","DOI":"10.1007\/s11356-020-07854-w","article-title":"Effects of fucoidan on the hematic indicators and antioxidative responses of Nile tilapia (Oreochromis niloticus) fed diets contaminated with aflatoxin B1","volume":"27","author":"Abdel-Daim","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"3","key":"10.1016\/j.crphar.2023.100159_bib2","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s11356-019-06931-z","article-title":"Fucoidan alleviates microcystin-LR-induced hepatic, renal, and cardiac oxidative stress and inflammatory injuries in mice","volume":"27","author":"AIKahtane","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.crphar.2023.100159_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijbiomac.2019.12.183","article-title":"Hepatoprotective effect of a fucoidan extract from Sargassum fluitans Borgesen against CCl4-induced toxicity in rats","volume":"145","author":"Chale-Dzul","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.crphar.2023.100159_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.biopha.2016.07.027","article-title":"Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells","volume":"83","author":"Cho","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.crphar.2023.100159_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cbi.2009.09.015","article-title":"Effect of fucoidan on aspirin-induced stomach ulceration in rats","volume":"183","author":"Choi","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.crphar.2023.100159_bib6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ptr.3138","article-title":"Toxicological evaluation of fucoidan from Undaria pinnatifida in vitro and in vivo","volume":"24","author":"Chung","year":"2010","journal-title":"Phytother Res."},{"issue":"5","key":"10.1016\/j.crphar.2023.100159_bib7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.kint.2017.04.048","article-title":"Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?","volume":"92","author":"Davenport","year":"2017","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.crphar.2023.100159_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/jcm11030636","article-title":"Adaptive mechanisms of renal bile acid transporters in a rat model of carbon tetrachloride-induced liver cirrhosis","volume":"11","author":"Donadei","year":"2022","journal-title":"J.\u00a0Clin. Med."},{"issue":"4","key":"10.1016\/j.crphar.2023.100159_bib9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: a systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J.\u00a0Hepatol."},{"issue":"9","key":"10.1016\/j.crphar.2023.100159_bib10","first-page":"352","article-title":"Updates on hepato-renal syndrome","volume":"4","author":"Fukazawa","year":"2013","journal-title":"J.\u00a0Anesth. Clin. Res."},{"issue":"26","key":"10.1016\/j.crphar.2023.100159_bib11","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.3748\/wjg.v27.i26.3984","article-title":"Acute kidney injury and hepatorenal syndrome in cirrhosis","volume":"27","author":"Gupta","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.crphar.2023.100159_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejphar.2007.11.015","article-title":"Fucoidan partly prevents CCl4-induced liver fibrosis","volume":"580","author":"Hayashi","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.crphar.2023.100159_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MNH.0000000000000374","article-title":"Bile acid receptors and the kidney","volume":"27","author":"Herman-Edelstein","year":"2018","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"5","key":"10.1016\/j.crphar.2023.100159_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1271\/bbb.100599","article-title":"Suppression by fucoidan of liver fibrogenesis via the TGF-beta\/Smad pathway in protecting against oxidative stress","volume":"75","author":"Hong","year":"2011","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"12","key":"10.1016\/j.crphar.2023.100159_bib15","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3390\/biomedicines9121847","article-title":"Hypothetical mechanism of exercise-induced acute kidney injury associated with renal hypouricemia","volume":"9","author":"Hosoyamada","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.crphar.2023.100159_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.25626","article-title":"Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation","volume":"56","author":"Jang","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.crphar.2023.100159_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.fct.2010.01.032","article-title":"Genotoxicity studies on fucoidan from Sporophyll of Undaria pinnatifida","volume":"48","author":"Kin","year":"2010","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.crphar.2023.100159_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.18097\/PBMC20176306553","article-title":"Evaluation of adjuvant effects of fucoidane from brown seaweed Fucus evanescens and its structural analogues for the strengthening vaccines effectiveness","volume":"63","author":"Kuznetsova","year":"2017","journal-title":"Biomed. Khim."},{"key":"10.1016\/j.crphar.2023.100159_bib19","first-page":"619","article-title":"Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-beta1\/Smad pathway-mediated inhibition of extracellular matrix and autophagy","volume":"10","author":"Li","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.crphar.2023.100159_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12985-017-0848-8","article-title":"Fucoidan from Fucus vesiculosus suppresses hepatitis B virus replication by enhancing extracellular signal-regulated Kinase activation","volume":"14","author":"Li","year":"2017","journal-title":"Virol. J."},{"issue":"7","key":"10.1016\/j.crphar.2023.100159_bib21","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1142\/S0192415X20500809","article-title":"Fucoidan: biological activity in liver diseases","volume":"48","author":"Li","year":"2020","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.crphar.2023.100159_bib22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/md13021051","article-title":"Fucoidan from Fucus Vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells","volume":"13","author":"Lim","year":"2015","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.crphar.2023.100159_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.34067\/KID.0002422021","article-title":"Bile acids are important contributors of AKI associated with lver disease: commentary","volume":"3","author":"Lopez-Ruiz","year":"2021","journal-title":"Kiney360"},{"key":"10.1016\/j.crphar.2023.100159_bib24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ijbiomac.2018.10.129","article-title":"Primary structure and anticoagulant activity of fucoidan from the sea cucumber Holothuria polii","volume":"121","author":"Mansour","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.crphar.2023.100159_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S0102-86502012000800013","article-title":"Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection","volume":"27","author":"Marques","year":"2012","journal-title":"Acta Cir. Bras."},{"issue":"10","key":"10.1016\/j.crphar.2023.100159_bib26","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1440-1746.2009.06187.x","article-title":"Attenuation of Nitrosodiethylamine-induced liver fibrosis by high-molecular-weight fucoidan derived from Cladosiphon okamuranus","volume":"25","author":"Nakazato","year":"2010","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"issue":"14","key":"10.1016\/j.crphar.2023.100159_bib27","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.crphar.2023.100159_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.intimp.2010.11.002","article-title":"Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats","volume":"11","author":"Raghavendran","year":"2011","journal-title":"Int. Immunopharm."},{"issue":"28","key":"10.1016\/j.crphar.2023.100159_bib29","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: a review","volume":"19","author":"S\u00e1nchez-Valle","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"3\u20134","key":"10.1016\/j.crphar.2023.100159_bib30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.fct.2011.11.010","article-title":"Genotoxicity testing of low molecular weight fucoidan from brown seaweeds","volume":"50","author":"Song","year":"2012","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.crphar.2023.100159_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.23265","article-title":"Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis","volume":"51","author":"Soroka","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.crphar.2023.100159_bib32","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1038\/s41598-021-86662-9","article-title":"Hypouricemic agents reduce indoxyl sulfate excretion by inhibiting the renal transporters OAT1\/3 and ABCG2","volume":"11","author":"Taniguchi","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.crphar.2023.100159_bib33","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.3390\/md13063514","article-title":"Fucoidan suppresses hypoxia-induced lymphangiogenesis and lymphatic metastasis in mouse hepatocarcinoma","volume":"13","author":"Teng","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.crphar.2023.100159_bib34","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2019.11.027","article-title":"Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome","volume":"152","author":"Trojnar","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.crphar.2023.100159_bib35","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/hep.29915","article-title":"Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome in mice","volume":"68","author":"Varga","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.crphar.2023.100159_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.11.035","article-title":"Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice","volume":"747","author":"Wang","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.crphar.2023.100159_bib37","article-title":"Fucoidan alleviates renal fibrosis in diabetic kidney disease via inhibition of NLRP3 inflammasome-mediated podocyte pyroptosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.crphar.2023.100159_bib38","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3390\/nu12103068","article-title":"Oligo-fucoidan improves diabetes-induced renal fibrosis via activation of Sirt-1, GLP-1R, and Nrf2\/HO-1: an in vitro and in vivo study","volume":"12","author":"Yu","year":"2020","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.crphar.2023.100159_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/md16120472","article-title":"Production inhibition and excretion promotion of urate by fucoidan from Laminaria japonica in adenine-induced hyperuricemic mice","volume":"16","author":"Zhang","year":"2018","journal-title":"Mar. Drugs"}],"container-title":["Current Research in Pharmacology and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259025712300007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259025712300007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:46:15Z","timestamp":1762922775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259025712300007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":39,"alternative-id":["S259025712300007X"],"URL":"https:\/\/doi.org\/10.1016\/j.crphar.2023.100159","relation":{},"ISSN":["2590-2571"],"issn-type":[{"value":"2590-2571","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fucoidan alleviates the hepatorenal syndrome through inhibition organic solute transporter \u03b1\/\u03b2 to reduce bile acids reabsorption","name":"articletitle","label":"Article Title"},{"value":"Current Research in Pharmacology and Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphar.2023.100159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100159"}}